Skip to main content
. 2022 Oct 27;14(10):1120–1130. doi: 10.4240/wjgs.v14.i10.1120

Table 2.

Long-term efficacy evaluation after cap-assisted endoscopic sclerotherapy treatment (follow-up in 2020, n = 201), n (%)

Efficacy
Excellent
Good
Poor
χ 2
P value
Stage Ⅰ 54 (61.4) 26 (29.5) 8 (9.1)
Stage Ⅱ 35 (66.1) 13(24.5) 5 (9.4) 8.90 0.177
Stage Ⅲ 34 (68.0) 13 (26.0) 3 (6.0)
Stage Ⅳ 3 (30.0) 3 (30.0) 4 (40.0)